scispace - formally typeset
Search or ask a question

What are the latest studies looking at epigenetics and cancer? 


Best insight from top research papers

Recent studies have focused on the role of epigenetic modifications in cancer progression and treatment. Epigenetic changes, such as histone modification, DNA methylation, and non-coding RNA, have been shown to play a critical role in the development of therapeutic resistance in cancer . Targeting these epigenetic modifications with specific drugs, such as DNA methyltransferase inhibitors and histone deacetylase inhibitors, has the potential to reverse drug resistance and restore sensitivity to standard therapies . Additionally, the interplay between epigenetics and cancer immunology has been explored, with the aim of developing therapeutics that combine both approaches . The concept of the epigenetic landscape, which describes potential cellular fates and regulatory processes, has been applied to understand cancer etiology and the plasticity of cancerous states . Advances in single-cell analysis and molecular assays have enriched our understanding of the diversity of phenotypic states defined by epigenetic control . Overall, these studies contribute to our understanding of how epigenetic modifications influence cancer progression and provide insights for the development of targeted therapies .

Answers from top 5 papers

More filters
Papers (5)Insight
The latest studies in epigenetics and cancer focus on the identification and characterization of epigenetic events within the tumor microenvironment (TME) for diagnostic, prognostic, and therapeutic purposes.
Journal ArticleDOI
Andrew P. Feinberg, Andre Levchenko 
10 Feb 2023-Science
9 Citations
The paper discusses recent developments in understanding the epigenetic landscape of cancer and how it relates to phenotypic plasticity and heterogeneity. It also explores the use of quantitative analyses to assess the connections between genetic and environmental drivers of cancer evolution. However, it does not specifically mention the latest studies in the field.
The paper discusses the potential of targeting epigenetic regulators for cancer immunotherapy and the interplay between epigenetics and cancer immunology. It does not specifically mention the latest studies on epigenetics and cancer.
The latest studies are looking at the epigenetic mechanisms of carcinogenesis and the interaction between epigenetic modification and cancer radiotherapy.
The paper discusses the potential of epigenetic drugs to overcome therapeutic resistance in epithelial malignancies, but it does not specifically mention the latest studies on epigenetics and cancer.

Related Questions

The importance of epigenetics on cancer stem cells?5 answersEpigenetics plays a crucial role in the behavior and characteristics of cancer stem cells (CSCs). CSCs, a small subset within tumors, exhibit stem cell-like properties and are resistant to conventional therapies, contributing to tumor initiation, progression, metastasis, and recurrence. Epigenetic modifications, such as DNA methylation, histone modifications, and regulatory RNAs, are key drivers in the formation and maintenance of CSCs. These modifications regulate gene expression patterns and pathways associated with cell proliferation and survival, impacting the plasticity and resistance of CSCs. Targeting epigenetic modifiers like LSD1, BMI1, G9a, and SETDB1 presents a promising strategy to eliminate CSCs, potentially reshaping the tumor microenvironment for improved cancer immunotherapy. Epigenetic therapies, including phenolic compounds, offer new avenues for controlling and treating cancer by targeting CSCs through epigenetic mechanisms.
Cancer and epigenetic alterations5 answersEpigenetic alterations play a crucial role in the development and progression of cancer. These alterations involve changes in DNA methylation, nucleosome remodeling, RNA-mediated targeting, and histone modification balance. They can activate the inhibition of gene transcription and contribute to the pathogenesis of various malignancies. DNA methylation, in particular, is a key epigenetic element that can lead to direct mutagenesis, hypomethylation of the cancer genome, and focal hypermethylation of tumor suppressor gene promoters. Aberrations in the epigenome, including alterations in the transcriptome, transcription factors, DNA, and chromatin regulatory proteins, have been linked to the development of drug resistance in cancer. Understanding these epigenetic factors and pathways is important for the prevention and treatment of drug-resistant cancer.
What are the latest trends in cancer research?4 answersCancer research has seen advancements in various areas. Exosomes research has contributed to understanding cancer mechanisms and developing detection and treatment methods. Microbiome research has helped in understanding the disease. Immunotherapy has emerged as a significant method in cancer treatment. Organoid biology is being developed for personalized therapy. Immuno-oncology, particularly immune checkpoint inhibitors, has shown efficacy in various tumors. Biomarker testing, such as PD-L1, is being used to guide immune checkpoint inhibition therapy. Combination therapies involving immune-oncology drugs have shown improved clinical outcomes. Challenges remain in terms of side effects, cost-effectiveness, and healthcare system integration. Overall, the latest trends in cancer research include exosomes, microbiome, immunotherapy, organoids, and immune-oncology drugs.
What are the recent advances in epigenetic research?5 answersRecent advances in epigenetic research include the study of epigenetic regulation in plant regeneration, the role of epigenetics in obesity and metabolic diseases, the technological advances enabling the study of epigenetic mechanisms in blood cells, the exploration of epigenetic mechanisms in cancer progression, and the potential of epigenetic research in non-small-cell lung cancer (NSCLC) management. Epigenetic regulation in plant regeneration has been studied in model plants like Arabidopsis thaliana. Epigenetics has been implicated in the development of obesity and its associated complications, with DNA methylation being the most investigated mechanism. Technological advances have allowed for the study of epigenetic mechanisms in blood cells at a higher resolution, providing insights into diseases like acute myeloid leukemia. Epigenetic markers have been identified in cancer progression, and research has focused on transcriptome analysis and genome targeting technologies. Epigenetic alterations have been studied in NSCLC for early detection, diagnosis, outcome prediction, and treatment options.
What are the main epigenetic factors in cancer?5 answersEpigenetic factors play a crucial role in cancer development and progression. These factors include histone alterations, polycomb/trithorax associated proteins, short non-coding RNAs, long non-coding RNAs (lncRNAs), and DNA methylation. Epigenetic modifications are heritable changes in gene expression that occur without altering the DNA sequence. They can influence the transcriptional potential of genes and are involved in normal growth and development. In cancer, epigenetic alterations are widely recognized as essential players in cancer progression and can occur at an early stage of neoplastic development. These alterations can be influenced by various factors, including diet, lifestyle, environment, and socioeconomic status. Understanding the impact of these epigenetic mechanisms may provide personalized prognostic tools for assessing cancer susceptibility and guiding cancer prevention strategies. Overall, epigenetic factors have significant implications in cancer biology and therapy, making them important targets for further research and therapeutic interventions.
If you could categorize the ways that metabolomics influences epigenomics in cancer cell, what it would be?1 answersMetabolomics influences epigenomics in cancer cells through various mechanisms. Firstly, the crosstalk between metabolism and epigenetics plays a crucial role in tumorigenesis. Oncogene-driven metabolic plasticity supports tumor growth and alters the epigenetic landscape. Conversely, epigenetic mechanisms can regulate the expression of metabolic genes, thereby altering the metabolome. Secondly, changes in nutrient uptake and utilization directly affect chromatin structure, highlighting the integration of genetic mutations with metabolic reprogramming and epigenetic shifts in cancer. Additionally, cancer cells exhibit epigenetic drifts, including genome-wide changes in DNA methylation, histone modifications, and chromatin structure, indicating the association between tumorigenesis and epigenetic reprogramming. Understanding the bidirectional relationship between metabolomics and epigenomics is crucial for identifying potential molecular targets for anti-cancer therapeutic strategies.

See what other people are reading

What is the association of nutrition and drug abuse?
5 answers
Nutrition plays a crucial role in the context of drug abuse. Substance abuse can lead to alterations in food preferences and dietary habits, impacting an individual's nutritional status. Substance users are at high risk of nutritional deficiencies due to hormonal alterations affecting appetite and eating patterns, as well as changes in nutrient absorption and metabolism. Drug-nutrient interactions are common and can influence drug absorption, metabolism, and clinical effects, potentially impacting health outcomes. Moreover, drug abuse can disrupt circadian metabolic profiles, increasing the risk of metabolic dysfunctions and diseases like metabolic syndrome. Addressing nutritional needs in substance use disorder (SUD) recovery programs can aid in faster recovery, reduce the risk of relapse, and improve overall health outcomes.
What is the process used to induce senescence in epidermal cells?
5 answers
Inducing senescence in epidermal cells involves the activation of p14^ARF, which leads to apoptosis, cell-cycle arrest, and subsequent p53-dependent senescence. This process requires continued expression of p14^ARF to commit cells to senescence, indicating a dependency on a persistent signal. Senescent cells formed in the epidermis are retained for extended periods even after transgene silencing, suggesting a lack of efficient removal mechanisms. Interestingly, epidermal hyperplasia induction can prevent the appearance of senescent cells upon p14^ARF activation. Understanding the dynamics of senescence induction in epidermal cells is crucial due to its implications in aging, tumor suppression, and tissue function.
What is known about the Long non Coding rna neat1?
5 answers
Long non-coding RNA (lncRNA) NEAT1 plays a crucial role in various biological processes. NEAT1 is involved in the regulation of internal ribosome entry sites (IRES) during stress, influencing the translation of (lymph)angiogenic and cardioprotective factor mRNAs. In keratinocytes, NEAT1 expression is repressed by the transcription factor ∆Np63 during proliferation, but increases upon differentiation, promoting the formation of paraspeckles and sustaining epidermal morphogenesis. NEAT1 has been shown to mediate cell proliferation, migration, and epithelial-mesenchymal transition in cancer cells, making it a potential biomarker for cancer diagnosis and treatment. Furthermore, NEAT1 is upregulated in hypoxic conditions, influencing the activation of the FGF1 IRES and endogenous FGF1 expression. These findings highlight the diverse roles of NEAT1 in cellular processes, ranging from epidermal development to cancer progression and stress response.
How bladder cancer grade heterogeneity impact patients outcome?
9 answers
Bladder cancer (BCa) exhibits significant heterogeneity, both between patients (inter-patient) and within individual tumors (intra-tumor), which profoundly impacts patient outcomes. Studies have shown that the degree of heterogeneity within a tumor, particularly the presence of mixed-grade non-muscle invasive bladder cancer (NMIBC), does not significantly predict recurrence rates, although the overall recurrence rate for mixed-grade tumors remains high. This suggests that while grade heterogeneity is a notable feature of bladder cancer, its direct impact on recurrence may not be as significant as previously thought, necessitating further research for clear stratification and treatment implications. Moreover, the molecular landscape of bladder cancer, characterized by varying levels of intra-tumor subtype heterogeneity, has been linked to patient prognosis. For instance, a higher class 2a weight estimated from bulk RNA-sequencing data is associated with worse outcomes in patients with molecular high-risk class 2a tumors. This indicates that molecular characteristics, including subtype heterogeneity, can serve as important prognostic factors. The development of a prognostic signature based on 15 genes involved in the extracellular matrix-associated pathway further underscores the importance of molecular heterogeneity in predicting BCa patient outcomes. This signature effectively separates patients into groups with favorable and poor prognoses, highlighting the potential for molecular classification to guide prognosis and treatment. Additionally, the mutational spectrum and intratumor heterogeneity (ITH) of bladder cancer, as measured by the mutant-allele tumor heterogeneity (MATH) algorithm, correlate with clinical parameters and mutational subtypes, affecting therapy resistance and survival outcomes. For example, patients with FGFR3 mutations and low MATH values exhibit longer overall survival, suggesting that measures of tumor heterogeneity could serve as useful biomarkers for prognosis. In summary, bladder cancer grade heterogeneity, particularly when considered alongside molecular and genetic heterogeneity, plays a critical role in influencing patient outcomes. The complexity of bladder cancer's heterogeneity necessitates a multifaceted approach to prognosis and treatment, leveraging molecular classifications and genetic markers to tailor therapeutic strategies.
What is the biological mechanism behind the development of allergies and sensitization?
4 answers
The development of allergies and sensitization involves a complex interplay of cellular and molecular mechanisms. Allergic diseases exhibit two phases: sensitization and effector functions, involving memory T and B cell responses, IgE production, and the activation of effector cells like eosinophils and dendritic cells. Environmental factors, such as pollution and lifestyle changes, influence allergy susceptibility through epigenetic mechanisms like DNA methylation and histone modifications. The MeDALL project highlighted the multimorbidity of allergic diseases and the role of epigenetics and transcriptomics in understanding allergies. Allergic endotypes are driven by type-2 immune responses, with type-2 innate lymphoid cells and T-helper 2 cells releasing key cytokines like IL-4, IL-13, and IL-5. Sensitization to allergens, particularly in chronic rhinitis, involves IgE-mediated mechanisms and the importance of detecting both systemic and local sensitization for accurate diagnosis and management.
How fluoxetine can act via (SQSTM1)/p62?
5 answers
Fluoxetine can potentially act via (SQSTM1)/p62 by influencing various cellular processes. Studies have shown that p62 is involved in maintaining redox homeostasis in tumor cells with elevated mTORC1, which could be a target for therapeutic interventions. Additionally, silencing SQSTM1/p62 expression has been linked to inhibiting breast cancer progression by regulating cell proliferation and reshaping the tumor microenvironment, providing a potential avenue for therapeutic strategies. Furthermore, p62 has been implicated in Alzheimer's disease pathogenesis, with genetic associations showing a relationship between SQSTM1 rs4935 and decreased β-amyloid levels in AD patients, suggesting a role in disease progression. Moreover, p62 is involved in the extracellular release of miR-198 in hepatocellular carcinoma, affecting gene expression in recipient cells, indicating a potential mechanism through which fluoxetine could exert its effects.
Which are the most important changes in plants as a result of climate change?
5 answers
Climate change induces various significant changes in plants, impacting their physiology and productivity. The elevated CO2 levels, water stress, extreme temperatures, and stress combinations negatively affect plant growth. These changes lead to alterations in plant physiology, reduced photosynthetic capacity, and metabolic responses to mitigate stress effects. Additionally, climate change affects the quality and yield of vegetable crops, leading to crop failures, low yields, and increased pest and disease issues. Furthermore, plants experience genome-wide epigenetic alterations in response to environmental stresses, influencing gene expression and phenotypic plasticity. High temperatures impact xylem and phloem formation, root growth, and nutrient uptake, affecting crop yield and quality. Overall, climate change poses a serious threat to plant health, productivity, and food supply, necessitating the development of stress-resilient crops.
Do keratinocytes produce IL-17 ?
5 answers
Keratinocytes have been identified as a significant source of IL-17 in various inflammatory skin conditions, including psoriasis. Studies have shown that human keratinocytes, particularly in psoriatic lesions, are the main producers of IL-17, specifically IL-36γ, which is induced by IL-17A. Furthermore, IL-17 can stimulate keratinocytes, leading to the production of specific cytokines and chemokines that attract Th17 cells. Additionally, IL-17 treatment of keratinocytes has been found to promote cell proliferation and increase the expression of MALAT1, a long non-coding RNA associated with psoriasis development. Therefore, keratinocytes play a crucial role in the production of IL-17 and its downstream effects in inflammatory skin disorders like psoriasis.
Who are some notable figures who have quotes the lack of planning and decision making?
4 answers
Notable figures have highlighted the significance of planning and decision-making. In the realm of clinical practice, the decision-making process involves assessing the restorability of a tooth, the patient's ability to tolerate treatment, and the clinician's expertise. In the context of internet searches for educational resources, a mathematics lesson planning protocol was developed to aid teachers in processing search results effectively. When dealing with isolated locoregional recurrence of breast cancer, a multidisciplinary approach is crucial for decision-making, considering factors like prior therapy and risk of distant metastases. In the realm of building rich Internet applications, the importance of making wise decisions that benefit both the individual and the team is emphasized. Lastly, in the field of ambulatory surgery, an analytical framework was created to assist surgeons in deciding between ambulatory and inpatient procedures, highlighting the need for informed decision-making in healthcare planning.
Mouse p53 의 mutation 중에서 gain of function 을 유발하는 알려진 사이트는?
5 answers
Known sites of gain-of-function mutations in mouse p53 include the R270H mutation, which is equivalent to the human hotspot R273H. Studies using conditional mouse models have shown that the epithelium-specific expression of the p53.R270H mutation results in an increased incidence of skin tumors, indicating gain-of-function properties. However, it is important to note that the gain-of-function effects of the p53.R270H mutation were not detected in skin epithelium, suggesting tissue-specific differences in mutant p53 effects. Additionally, comparisons between different p53 mutations in mice, such as R245W and R270H, have highlighted specific gain-of-function contributions to tumor development, with contact mutations like R245W and R270H showing stronger abilities to drive osteosarcoma metastasis.
How CAR-T cell therapy has been used in blood cancer and solid cancer?
5 answers
CAR-T cell therapy has been successfully employed in treating blood cancers like B-cell acute lymphoblastic leukemia, large B-cell lymphoma, and multiple myeloma by targeting specific antigens such as CD-19 and B-cell maturation antigens. However, its application in solid tumors faces challenges like inadequate tumor infiltration, immunosuppressive microenvironments, and the absence of reliable tumor-associated antigens. To enhance CAR-T cell efficacy in solid tumors, strategies such as incorporating chemokine receptors, utilizing immune checkpoint inhibitors, and developing hydrogel platforms for regional CAR-T cell administration have been proposed. Additionally, advancements in CAR-T cell design, including the use of co-stimulatory domains and armored CAR-T cells, show promise in overcoming these challenges. Efforts are ongoing to optimize CAR-T cell therapy for improved outcomes in solid cancer treatment.